Veeva Systems Inc. $VEEV Shares Purchased by Praxis Investment Management Inc.

Praxis Investment Management Inc. boosted its position in Veeva Systems Inc. (NYSE:VEEV) by 26.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,920 shares of the technology company’s stock after purchasing an additional 830 shares during the quarter. Praxis Investment Management Inc.’s holdings in Veeva Systems were worth $1,129,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Veeva Systems by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 14,760,566 shares of the technology company’s stock valued at $3,418,990,000 after acquiring an additional 315,421 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of Veeva Systems by 10.7% during the 1st quarter. Alliancebernstein L.P. now owns 5,499,651 shares of the technology company’s stock valued at $1,273,884,000 after acquiring an additional 532,269 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its stake in shares of Veeva Systems by 0.7% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,203,867 shares of the technology company’s stock valued at $1,205,372,000 after acquiring an additional 34,169 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Veeva Systems by 20.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock valued at $924,754,000 after acquiring an additional 689,700 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Veeva Systems by 7.5% during the 1st quarter. JPMorgan Chase & Co. now owns 3,230,758 shares of the technology company’s stock valued at $748,341,000 after acquiring an additional 225,125 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Analysts Set New Price Targets

VEEV has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Veeva Systems in a research note on Wednesday, October 8th. Barclays upped their price objective on shares of Veeva Systems from $300.00 to $325.00 and gave the company an “overweight” rating in a research note on Thursday, August 28th. Wall Street Zen raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research report on Saturday, October 11th. Stifel Nicolaus increased their target price on shares of Veeva Systems from $295.00 to $320.00 and gave the stock a “buy” rating in a research report on Thursday, August 28th. Finally, TD Cowen raised shares of Veeva Systems from a “hold” rating to a “buy” rating and increased their target price for the stock from $297.00 to $380.00 in a research report on Tuesday, October 7th. Seventeen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Veeva Systems presently has an average rating of “Moderate Buy” and a consensus target price of $307.58.

Veeva Systems Stock Down 3.0%

NYSE VEEV opened at $283.96 on Friday. The stock has a market cap of $46.54 billion, a PE ratio of 58.31, a P/E/G ratio of 2.26 and a beta of 0.98. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The business has a 50 day moving average price of $283.44 and a two-hundred day moving average price of $266.73.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). The company had revenue of $789.08 million during the quarter, compared to analysts’ expectations of $768.49 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The firm’s revenue was up 16.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Sell-side analysts anticipate that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Insiders Place Their Bets

In other Veeva Systems news, SVP Jonathan Faddis sold 14,595 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.00, for a total value of $4,378,500.00. Following the completion of the transaction, the senior vice president owned 8,588 shares in the company, valued at $2,576,400. This represents a 62.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas D. Schwenger sold 3,350 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the transaction, the insider owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 in the last 90 days. 10.30% of the stock is owned by company insiders.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.